Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Kidney Failure, Chronic × belantamab mafodotin × 1 year × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Genitourinary 1

Conditions

Multiple Myeloma 35 Recurrence 5 Neoplasms, Plasma Cell 3 Immunoglobulin Light-chain Amyloidosis 3 Amyloidosis 2 Renal Insufficiency 1 Plasmablastic Lymphoma 1 Kidney Failure, Chronic 1 Corneal Diseases 1

Interventions

belantamab mafodotin 1 Standard of Care 1 Pancreatectomy 1 Palliative Care 1 Kidney Transplantation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04398745 2025-05-23

DREAMM12

GlaxoSmithKline

Phase 1 Active not recruiting

GenitourinaryPlasma cell

Kidney Failure, Chronic, Multiple Myeloma, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon ⚡